Experiments were conducted to determine the role of estrogens on endogenous PGF~ c~ secretion and luteolysis following injection of cloprostenol in heifers. In Exp. 1, eight luteal-phase heifers were used to evaluate tarnoxifen (T) as an estrogen antagonist. Heifers received T (35 mg i.v.) or ethanol:saline vehicle (ES) every 4 h for 44 h. All received cloprostenol (500/~g i.m.) immediately after the start of T or ES, and received estradiol-17fl (500/~g i.m.) 12 h later. Each ES heifer had a surge of luteinizing hormone (LH) within 48 h of estradiol injection, whereas T-treated heifers did not. Estrus was observed in three ES-treated heifers, but not in T-treated heifers. In Exp. 2, 10 heifers received T (35 mg i.v.) or ES every 4 h for 64 h beginning on d 15 postestrus. Cloprostenol (500 ~g i.m.) was injected 16 h after the start of treatment. Concentrations of LH were similar (P > .05) in both groups. In ES heifers, concentrations of 13,14-dihydro-15-keto-prostaglandin F 2 c~ (PGFM) increased; in T-treared heifers, PGFM remained at pre-cloprostenol levels. Luteolysis was induced in all heifers. Progesterone (P4) decreased to < 1 ng/ml at similar (P > .05) rates in EStreated and T-treated heifers. Mean concentration of P4 288 h post-cloprostenol was greater (P < .05) in ES-treated than in T-treated heifers. Three ES-treated heifers, but no T-treated heifers, were in standing estrus. We conclude that T effectively antagonizes estrogen in cattle. Cloprostenol treatment is followed by an endogenous, estrogen-dependent secretion of PGF 2 a. However, this secretion does not appear to be required for cloprostenol-induced luteotysis.
Introduction
Prostaglandin F 2 a (PGF2(~) and its analogue, cloprostenol, are luteotytic in cattle (Lauderdale, 1972; Rowson et al., 1972) . Their administration is often followed by endogenous secretion of estradiol-17fl (Hixon et al., 1973; Hixon and Hansel, 1974; Stellflug et al., 1977; Fogwell et al., 1978) and PGF2(x (Challis et al., gens may exert their luteolytic effect in cattle by stimulating endogenous PGF2a secretion (Bartol et al., 1981; Knickerbocker et al., 1986; Thatcher et al., 1986) .
Destruction of ovarian follicles inhibited luteolysis in heifers with intact uteruses (Hughes et al., 1987) and in ewes (Hixon et al., 1975) . However, the mechanism of this inhibition is not known, because Gengenbach et al. (1977) demonstrated a luteolytic interaction between estradiol and PGF2a in ewes independent of the uterus.
The objectives of the present experiment were to determine whether estrogens have a role in luteolysis induced by a standard dose of cloprostenol (500 /ag) in heifers and to determine whether this role is mediated through endogenous PGF 2 a secretion.
Materials and Methods
In Exp. 1, eight crossbred beef heifers, each with a functional corpus luteum as determined by ovarian palpation, were assigned randomly to receive either 35 mg tamoxifen (trans -1 -(p-fl-di-methylaminoethoxy -phenyl)-1,2-diphenylbut-l-ene; n = 4) or vehicle (n = 4) every 4 h for 44 h. Tamoxifen (T) was dissolved in a 1:1 solution of ethanohsaline and was injected in a volume of 3 ml through jugular cannulas. All heifers received an injection of cloprostenol (500 /ag i.m.) immediately after the start of tamoxifen or ethanol:saline vehicle (ES) followed 12 h later by estradiol-17/3 (500/ag i.m.). In cattle with functional corpora lutea, these treatments (cloprostenol, estradiol) will result in ovulatory surges of luteinizing hormone (LH) approximately 24 h post-estradiol (Schillo et al., 1983) .
Immediately before each injection of T or ES, blood samples were taken from jugular canhulas and allowed to clot at 4 ~ C. Serum was separated by centrifugation within 6 h and frozen (-15 ~ C) until assayed for LH and progesterone. Beginning immediately after the blood sampling period, heifers were put on pasture and observed for estrus three times daily for 3 d.
In Exp. 2, 10 crossbred beef heifers were given two injections of cloprostenol (500 ttg i.m.) 11 d apart to induce luteolysis and to synchronize estrus. On d 15 postestrus, heifers were assigned randomly to receive either 35 mg T (n = 5) or ES (n = 5) every 4 h for 64 h. Tamoxifen was dissolved in a 1:1 solution of ethanol:saline and was injected in a volume of 5 ml. All heifers received an injection of cloprostenol (500 /~g i.m.) 16 h after the start of T or ES. Blood samples were taken from jugular cannulas every hour for 51 h beginning 2 h prior to cloprostenol injection. In addition, one blood sample was taken via jugular venipuncture 12 d after cloprostenol. Blood samples were allowed to clot at 4 ~ C. Serum was separated by centrifugation within 6 h and frozen (-15 ~ C) until assayed for progesterone, 13-14-dihydro-15-keto-prostaglandin F2~ (PGFM) and LH.
Heifers were observed for estrus three times daily for 3 d beginning 50 h after cloprostenol. Ovaries were palpated per rectum immediately after the sampling period and 10 d after cloprostenol injection.
Statistical Analysis. In Exp. 1, baseline concentrations of LH were defined as the mean concentration of LH before estradiol administration (0, 4, 8, 12 h) . A surge of LH was defined as an increase in LH that exceeded baseline concentrations by a minimum of 10 ng/ml. The incidence of LH surges in T-treated and EStreated heifers was compared by chi-square analysis.
In Exp. 2, autocorrelations with a lag of 1 h for the mean concentrations of PGFM over the 51-h sampling period were determined using time series analysis (SAS. 1982). In a second analysis, mean concentrations of PGFM were calculated for each heifer for five periods. Period 1 consisted of the time before cloprostenol injection (--2, -1, 0 h). Periods 2 to 5 represented each successive 12-h period. Mean concentrations of PGFM during these five periods were subjected to analysis of variance for repeated measures (Gill and Hafs, 1971) . Comparisons between ES-treated and T-treated heifers were made within periods using Student's t-test. Concentrations of LH at 3-h intervals were compared by analysis of variance for repeated measures. The rate of progesterone decline after cloprostenol injection was characterized by linear regression. The mean progesterone concentration before cloprostenol administration (--2, -1, 0 h) was used as the first time period. Slopes and y-intercepts for the linear regression equation were compared by analysis of variance. In addition, mean time for progesterone concentrations to decrease to less than 1 ng/ml was compared by Student's t-test. To assess functional status of corpora lutea on d 12 after cloprostenol, mean progesterone concentrations at 288 h after cloprostenol injection were compared by Student's t-test.
Radioimmunoassays. Progesterone was measured by radioimmunoassay as described by Saunders et al. (1983) . In the present assay, volumes of 50, 200 and 400 /zl of pooled bovine sera yielded 94, 111 and 113%, respectively, of progesterone on a ng/ml basis relative to 100 /al serum. Recoveries of .05, .1, .2, .4, .8, 1.6 and 3.2 ng progesterone added to 100 /al serum were 88, 97, 107, 98, 105, 113 and 94%, respectively, of added progesterone on a ng/ml basis. Sensitivity of this assay was .05 ng progesterone/tube. Intraassay and interassay coefficients of variation were 8.1% and 9.6%.
Luteinizing hormone concentrations were measured by radioimmunoassay as described by Edgerton and Baile (1977) . In the present assay, volumes of 25, 50, 75 and 200 /~1 of pooled bovine serum yielded 96, 105, 105 and 84%, respectively, of LH on a ng/ml basis, relative to 100 /al serum. Recoveries of .1, .2, .4, .8 and 3.2 ng LH added to 100/zl pooled bovine serum were 110, 113, 102, 93 and 113%, respectively, of added LH on a ng/ml basis. Sensitivity of this assay was .05 ng/tube. Intraassay and interassay coefficients of variation were 8.4% and 10.2%. All samples for each experiment were run in one assay.
Concentrations of PGFM were measured in heat-dried ethyl ether extracts of 300-/al aliquants of acidified (50/al 1 N HC1) serum. Stan-dards of PGFM ranged from 12.5 to 800 pg. Goat anti-PG FM (100/al) was d fluted (1 : 13,000) in normal goat serum (1:200 in .01 M phosphate buffered saline with .1% gelatin [gel PBS]). Tubes were incubated at room temperature for 2 h before 3 H-PGFM (150 ~zl in gel PBS; approximately 12,000 cpm) was added. Tubes were then incubated at 4 ~ C overnight (approximately 15 h). Sheep anti-goat gamma globulin (100 /al) was added, and tubes were incubated at room temperature for 1 h before 3 ml of 25% ammonium sulfate in PBS was added to precipitate the bound antibody.
Specificity of the goat anti-PGFM was determined by the Upjohn Co., Kalamazoo, MI (K. Kirton, personal communication). Compounds tested and relative cross-reactivity with PGFM were: 15 keto PGF2a, 20%; C-16 urinary Metabolites of PGF2a, < 1%; 13,14-dihydro-PGF2~, .5%; PGF2 a, < .1%. In our laboratory, the cross-reactivity of cloprostenol at 50% binding was < .00001% relative to PGFM. Volumes of 100, 300, 400 and 500 #1 of pooled bovine serum yielded 115, 91, 108 and 112%, respectively, of PGFM on a pg/ml basis, relative to 200 /al serum. Recoveries of 25, 50, 100 and 400 pg PGFM added to 300/al pooled bovine serum were 111, 94, 116 and 96%, respectively, of added PGFM on a pg/ml basis. Sensitivity of this assay was 12.5 pg/tube. Intraassay and interassay coefficients of variation were 7.9% and 10.2%.
Results

Experiment 1. Individual patterns of proges-
terone and LH secretion during the 44-h sampling period of Exp. 1 are shown in Figure 1 . Serum concentrations of progesterone at 0 h ranged from 1.8 to 7.1 ng/ml, indicating that a functional corpus luteum was present in each heifer at the start of the experiment. Mean concentrations of progesterone at 0 h in EStreated (4.1 -+ 2.2 ng/ml) and T-treated (4.5 + 1.4 ng/ml) heifers were similar (P > .05). It appeared that luteolysis was induced in all heifers, because in each animal progesterone concentrations were < .5 ng/ml at 24 and 44 h after cloprostenol.
After cloprostenol-induced luteolysis, ES heifers responded to exogenous estradiol with preovulatory-like surges of LH that reached maximum concentrations of 81, 33, 82 and 66 ng/ml approximately 16 h post-estradiol (Figure 1) . In contrast (P < .05), LH remained at pre-estradiol levels throughout the sampling period in T-treated heifers.
Three of four ES heifers exhibited standing estrus as compared with zero of four T-treated heifers (P < .1). In addition, vulvar swelling was observed toward the end of the sampling period in ES heifers, but not in T-treated heifers.
Experiment 2. Mean concentrations of
PGFM during the 51-h sampling period of Exp. 2 are presented in Figure 2 . Mean concentrations of PGFM in T-treated heifers remained constant throughout the sampling period. In contrast, PGFM in ES heifers increased gradually until it reached maximum concentrations at approximately 23 h. Autocorrelation with a lag of 1 h indicated that the pattern of PGFM in T-treated heifers was random (P > .05), whereas PGFM concentrations in ES heifers changed nonrandomly (P < .05). Average concentrations of PGFM for the initial 2-h period and subsequent 12-h periods are shown in Figure 3 . Analysis of variance indicated a significant effect of period as well as a significant period • treatment interaction. This appeared to be largely due to increased PGFM in ES heifers during periods 3 to 5. Mean concentrations of PGFM in T-treated heifers were less than (P < .04) in ES heifers during periods 3 (189 -+ 11 vs 252 +-21 pg/ml) and 4 (181 + 12 vs 253 +-21 pg/ml).
Progesterone (P4) data for T-treated and ES heifers after cloprostenol administration are summarized in Table 1 . All heifers underwent luteolysis whether they were treated with T or not. The time required for P4 to reach concentrations of < 1 ng/ml was similar (P > .05) for both groups. Slopes and y-intercepts for the linear regression of P4 over time were similar (P > .05) for T-treated and ES heifers. Mean P4 concentrations 288 h after cloprostenol were greater (P < .05) in ES heifers than in T-treated heifers. Concentrations of LH are presented in Figure 4 . There were no effects (P > .05) of treatment, time or treatment x time on LH secretion.
Three of five ES heifers were observed in standing heat during the 3 d following the sampiing period, as compared with zero of five Ttreated heifers. Immediately after the blood sampling period, luteal structures could not be detected by ovarian palpation. However, palpation 10 d after cloprostenol revealed the presence of luteal tissue in all ES heifers, but revealed no structures on ovaries of T-treated 
DISCUSSION
Inhibition of estrogen-induced LH secretion
in Exp. 1 demonstrated that T antagonizes estrogens in cattle. This is consistent with inhibition of other estrogen-dependent actions by T in rats, such as ovulation (Labhsetwar, 1970) , iraplantation (Harper and Walpole, 1967) and uterine production of prostaglandins in vitro (Fenwick et al., 1977) .
In addition to inhibiting estradiol-induced LH secretion, T inhibited behavioral estrus. during the blood sampling periods when heifers were not able to interact with each other. However, T also appears to have prevented ovulation, because in Exp. 2 there was an absence of palpable luteal tissue on d 12 after cloprostenol, and progesterone concentrations at that time were lower than those normally observed during the luteal phase. Lack of ovulation within a few days of luteolysis can be readily explained due to inhibition of the LH surge. However, the absence of palpable luteal tissue 12 d later indicates that subsequent follicular development and ovulation was inhibited for a much longer period. Although the present study was not designed to clarify the nature of these persisting actions of T, this observation suggests that future studies might utilize this compound to explore the role of estrogen in follicular development.
In Exp. 1, T-treated heifers did not exhibit vulvar swelling or mucus discharge, both of which were observed in ES animals toward the end of the sampling period. The ability of T to inhibit these estrogen-dependent events is consistent with the ability of this class of compounds to compete with estrogens for binding sites in a wide variety of tissues, including the uterus and vagina (Terenius, 1970; Fenwick et al., 1977) as well as in the pituitary gland and hypothalamus (Kato et al., 1968) . In Exp. 2, ES-treated and T-treated heifers could not be distinguished based on degree of vulvar swelling and mucus discharge. The presence of some vulvar swelling and mucus discharge in T-treated heifers in Exp. 2 is difficult to explain in view of its inhibition of other estrogen-dependent events in that experiment. The difference in response could be due to the time of T administration. Whereas T was administered on d 15 after estrus in Exp. 2, the exact day of the cycle for heifers in Exp. 1 was not known. Tamoxifen may act differently at different stages of the cycle.
In ES heifers PGFM increased at the time of cloprostenol-induced luteolysis, consistent with other studies in cattle (Kindahl et al., 1980) and sheep (Challis et al., 1976) . Several studies have indicated that prostaglandins are released in a pulsatile pattern during spontaneous luteolysis (Peterson et al., 1975; Kindahl et al., 1976 Kindahl et al., , 1981 . Smith et al. (1979) suggested that the decrease in P4 during spontaneous luteolysis initiates such pulses of PGF2~,. However, because the pattern of PGFM following cloprostenol treatment in this study was not pulsatile, our results do not support such a role for decreasing concentrations of P4-
The ability of T to block the increase in PGFM indicates an estrogen-dependent release of PGF2a. This is consistent with experiments in which exogenous estrogen increased jugular venous concentrations of PGFM , ovarian venous PGFM and PGF2e (Knickerbocker et al., 1986) and intraluminal uterine PGF (Bartol et al., 1981 ). An alternative explanation for lower concentrations of PGFM in T-treated heifers is that metabolism of PGF20 ~ to PGFM is inhibited. However, exogenous cloprostenol increased PGF2a secretion in vivo (Challis et al., 1976) and T decreased uterine production of PGF2~ in vitro (Fenwick et al., 1977) . These observations indicate that lower PGFM concentrations in T-treated heifers result from reduced PGF2~ secretion rather than from reduced metabolism.
The argument for a role for estrogens in prostaglandin-induced luteolysis stems from the maintenance of corpora lutea in cows (Hughes et al., 1987) and ewes (Hixon et al., 1975) given a luteolytic challenge of PGF2~ following destruction of ovarian follicles. This may be: due to lack of estrogenic stimulation of endogenous PGF20o because hysterectomy (Brunner et al., 1969) and indomethacin (Lewis and Warren, 1974 ) inhibit estradiol-induced luteolysis in cattle.
Increased PGFM in control heifers in the present study is consistent with this proposed mechanism. However, this increase did not appear to contribute to luteolysis. This result is not surprising, because PGFM did not increase until approximately 16 h after cloproStenol, a time when progesterone concentrations had already declined to almost 1 ng/ml. Also, PGFM concentrations associated with spontaneous luteolysis (Peterson et al., 1975; Kindahl et al., 1976 Kindahl et al., , 1981 are greater than those measured in our study.
In addition to a direct effect on PGF2~, secretion, estrogens may act independently of the uterus to reduce luteal function (Gengenbach et al., 1977; Stellflug et al., 1977) . This may involve pituitary support of luteal tissue, because inhibition of PGF20cinduced (Hughes et al., 1987) or spontaneous (Villa-Godoy et al,, 1985) luteolysis by follicular destruction was associated with increased LH concentrations in cattle. In our study, concentrations of LH in EStreated and T-treated heifers were similar throughout the sampling period. This result is consistent with the inability of T to modify cloprostenol-induced luteal regression.
Failure of T-treated heifers to maintain functional corpora lutea may relate to dosage or type of prostaglandin administered. Hughes et al., (1987) used 15 mg of PGF2a, only 60% of the optimal dosage, to induce posttreatment estrus in heifers (Lauderdale, 1979) . Similarly, Hixon et al., (1975) used 7 mg PGF2a, a minimal dosage, to induce luteolysis in sheep (Douglas and Ginther, 1973) . Because neither of these studies, nor the present study, utilized more than one dose or form of prostaglandin, it iS not possible to assess the effect of these differences. The standard recommended dose of cloprostenol (500 /ag), not a minimal luteolytic dose, was used in the present study. This may have masked luteolytic effects of estrogens during cloprostenol-induced luteolysis. Thus, form or dosage of the luteolysin may explain the ability of follicular destruction to inhibit PGF2a-induced luteolysis (Hixon et al., 1975; Hughes et al., 1987) and the failure of T to do so. Alternatively, removal of follicular products other than estrogens may be responsible for inhibiting luteolysis. At the present dose of cloprostenol, our results do not support a role for estrogens in cloprostenol-induced luteolysis, because all heifers underwent luteolysis, and the rate of progesterone decline was similar in ES-treated and T-treated heifers.
In summary, administration of cloprostenol to induce luteolysis was followed by secretion of endogenous PGF2a and this secretion was estrogen-dependent. However, the increase in PGF2 a after cloprostenol, and hence this estrogen action, was not a prerequisite for luteolysis.
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